SCHEMBL6599567

SCHEMBL6599567

Cc1ncn(CCCOCc2ccccc2)c1C(O[SiH](C)C)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C19 P33261 2/20 0.34
AGER Q15109 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 5/20 0.33
MAPT P10636 4/20 0.33
L3MBTL1 Q9Y468 4/20 0.33
TP53 P04637 2/20 0.33
HTT P42858 2/20 0.33
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
TEAD3 Q99594 1/20 0.32
SMN1; SMN2 Q16637 6/20 0.31
NPC1 O15118 1/20 0.31
NFKB1 P19838 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6598215 0.86 TDP1 (0.35) CYP3A4CYP2C9CYP2D6CYP2C19LMNA
SCHEMBL6599978 0.85 SMN1; SMN2 (0.36) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL6599697 0.72 ATP4A (0.42) CYP1A2CYP3A4CYP2C9CYP2D6CYP2C19
SCHEMBL6599808 0.72 MEN1 (0.40) CYP1A2CYP3A4CYP2C9CYP2D6CYP2C19
SCHEMBL6599562 0.71 DUT (0.37) CYP1A2CYP3A4CYP2C9CYP2D6CYP2C19
SCHEMBL6598867 0.65 MEN1 (0.33) MEN1KMT2ALMNAL3MBTL1KDM4E
SCHEMBL9468726 0.63 PLA2G4B (0.36) CYP3A4MEN1KMT2ALMNAMAPT
SCHEMBL9468870 0.62 PLA2G4B (0.36)
SCHEMBL5196526 0.62 PDGFRB (0.41) CYP3A4KMT2ALMNAHTTHPGD
SCHEMBL26189830 0.61 TSHR (0.67) LMNAL3MBTL1KDM4ETEAD3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1169320-B1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2004-09-22 EP disclosed
US-6511978-B1 For treating cancer, restenosis, atherosclerosis or viral infections LG LIFE SCIENCES, LTD. (KR) 2003-01-28 US disclosed
EP-1169320-A4 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2002-10-30 EP disclosed
EP-1169320-A1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG Chem Investment, Ltd. (KR) 2002-01-09 EP disclosed
WO-2000064891-A1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD. (KR) 2000-11-02 WO disclosed